Population Pharmacokinetics and Exposure-Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes.
about
Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic PopulationsPopulation Pharmacokinetic- Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus.
P2860
Population Pharmacokinetics and Exposure-Response (Efficacy and Safety/Tolerability) of Empagliflozin in Patients with Type 2 Diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population Pharmacokinetics an ...... Patients with Type 2 Diabetes.
@en
Population Pharmacokinetics and Exposure-Response
@nl
type
label
Population Pharmacokinetics an ...... Patients with Type 2 Diabetes.
@en
Population Pharmacokinetics and Exposure-Response
@nl
prefLabel
Population Pharmacokinetics an ...... Patients with Type 2 Diabetes.
@en
Population Pharmacokinetics and Exposure-Response
@nl
P2093
P2860
P1433
P1476
Population Pharmacokinetics an ...... Patients with Type 2 Diabetes.
@en
P2093
Kyle T Baron
Matthew Riggs
Silke Retlich
Sreeraj Macha
Uli C Broedl
Valerie Nock
P2860
P2888
P304
P356
10.1007/S13300-016-0174-Y
P577
2016-06-16T00:00:00Z